Summarized by Masters of Longevity from Nature - Main.
A science-news article previewing a small clinical trial testing modified bone-marrow cells as a potential one-time treatment to rebuild bones in people with severe osteoporosis, written to highlight the study’s approach and implications for future research.
Key Takeaways
- Ten women with advanced osteoporosis received autologous mesenchymal stromal cells modified with added fucose to enhance bone homing.
- Reported fracture rate fell from roughly every one to two years before treatment to about once per decade after treatment.
- The trial was small, uncontrolled, and most participants continued conventional osteoporosis drugs during follow-up.
